Case-control study of hyperhomocysteinemia in cancer-bearing patients in a internal medicine department;Étude cas témoin évaluant l'incidence de l'hyperhomocystéinémie chez des patients porteurs de néoplasie dans un service de médecine interne

Revue de Medecine Interne

Volumn 28, Issue 8, 2007, Pages 520-525

  Falvo, N ^a   Ghiringhelli, F ^b   Berthier, S ^a   Bonnotte, B ^a,b   Lorcerie, B ^a  

^a HÔPITAL DU BOCAGE   (France)

^b INSERM   (France)

Author keywords

Cancer; Hyperhomocysteinemia; Thromboembolic disease

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD LEVEL; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; PATHOPHYSIOLOGY; PROSTATE CANCER; RISK FACTOR; STOMACH CANCER; TUMOR GROWTH; VENOUS THROMBOEMBOLISM; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; FOLLOW UP; MIDDLE AGED; NEOPLASM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; NEOPLASMS;

EID: 34447569310     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.04.003     Document Type: Article

References (47)

1. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324 (1991) 1149-1155
2. Boers G.H., Smals A.G., Trijbels F.J., Fowler B., Bakkeren J.A., Schoonderwaldt H.C., et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313 (1985) 709-715
3. Den Heijer M., Rosendaal F.R., Blom H.J., Gerrits W.B., and Bos G.M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb. Haemost. 80 (1998) 874-877
4. Wall R., Harlan J.M., Harker L.A., and Striker G.E. Homocysteine-induced endothelial cell injury in vitro: a model for study of vascular injury. Tromb. Rest. 18 (1980) 113-121
5. Starkebaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77 (1986) 1370-1376
6. Stein P.D., Beemath A., Meyers F.A., Skaf E., Sanchez J., and Olson R.E. Incidence of venous thromboembolism in patients hospitalized with cancer. Am. J. Med. 119 (2006) 60-68
7. Prandoni P. Venous thromboembolism risk and management in women with cancer and thrombophilia. Gend. Med. 2 Suppl A (2005) S28-S34
8. Pavic M., Debourdeau P., Aletti M., Farge-Bancel D., and Rousset H. Maladie thromboembolique et cancer. Rev. Med. Interne 27 (2006) 313-322
9. Trousseau A. Thrombose veineuse profonde des membres inférieurs. In: Trousseau A. (Ed). Clinique médicale de l'Hôtel Dieu de Paris (1865), Baillière, Paris 654-712
10. Baron J.A., Gridley G., Weiderpass E., Nyren O., and Linet M. Venous thromboembolism and cancer. Lancet. 1998; 351: 1077-80. Erratum in. Lancet 355 (2000) 758
11. Sorensen H.T., Mellemkjaer L., Steffensen F.H., Olsen J.H., and Nielsen G.L. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N. Engl. J. Med. 338 (1998) 1169-1173
12. Nordstrom M., Lindblad B., Anderson H., Bergqvist D., and Kjellstrom T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 308 (1994) 891-894
13. Murchison J.T., Wylie L., and Stockton D.L. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br. J. Cancer 91 (2004) 92-95
14. Rongioletti M., Baldassini M., Papa F., Capoluongo E., Rocca B., Cristofaro R.D., et al. Homocysteinemia is inversely correlated with platelet count and directly correlated with sE- and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase. Platelets 16 (2005) 185-190
15. Carson N., and Neill D. Metabolic abnormalities detected in a survey of mentally backward individuals in northern Ireland. Arch. Dis. Chil. 324 (1962) 1149-1155
16. Rampersaud G.C., Kauwell G.P., and Bailey L.B. Folate: a key to optimizing health and reducing disease risk in the elderly. J. Am. Coll. Nutr. 22 (2003) 1-8 (Review)
17. Brzozowska A., Sicinska E., and Roszkowski W. Role of folates in the nutrition of the elderly. Rocz. Panstw. Zakl. Hig. 55 (2004) 159-164
18. Mc Cully K.S. Homocystéine and vascular desease. Nat. Med. 2 (1996) 386-389
19. Soria C., Chadefaux B., Coude M., Gaillard O., and Kamoun P. Concentrations of total homocysteine in plasma in chronic renal failure. Clin. Chem. 36 (1990) 2137-2138
20. Hultberg G.B., Berglund M., and Frank A. Elevated plasma homocysteine in alcoholics. Alcohol. Clin. Exp. Res. 17 (1993) 687-689
21. Hultberg B., Agardh E., Andersson A., Brattstrom L., Isaksson A., Israelsson B., et al. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand. J. Clin. Lab. Invest. 51 (1991) 277-282
22. Welch G.N., Upchurch Jr. G.R., Farivar R.S., Pigazzi A., Vu K., Brecher P., Keaney Jr. J.F., et al. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2. Proc. Assoc. Am. Physicians 110 (1998) 22-31
23. Petri M., Roubenoff R., Dallal G.E., Nadeau M.R., Selhub J., and Rosenberg I.H. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 26 348 (1996) 1120-1124
24. Sengul E., Cetinarslan B., Tarkun I., Canturk Z., and Turemen E. Homocysteine concentrations in subclinical hypothyroidism. Endocr. Res. 30 (2004) 351-359
25. Hughes R., Harries M., Chalmers R.J., and Kirby B. Folic acid supplementation and methotrexate therapy for psoriasis. J. Am. Acad. Dermatol. 55 (2006) 366-367
26. Ruud E., Holmstrom H., Brosstad F., and Wesenberg F. Children with acute lymphoblastic leukaemia have high plasma levels of total homocysteine at time of diagnosis. Scand. J. Clin. Lab. Invest. 66 (2006) 67-78
27. Bienvenu T., Ankri A., Chadefaux B., Montalescot G., and Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Thromb. Res. 70 (1993) 123-129
28. Sterba J., Dusek L., Demlova R., and Valik D. Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited. Clin. Chem. 52 (2006) 692-700
29. Papakostas G.I., Petersen T., Mischoulon D., Ryan J.L., Nierenberg A.A., Bottiglieri T., et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J. Clin. Psychiatry 65 (2004) 1090-1095
30. Bissonnette R., Treacy E., Rozen R., Boucher B., Cohn J.S., and Genest Jr. J. Fenofibrate raises plasma homocysteine levels in the fasted and fed states. Atherosclerosis 155 (2001) 455-462
31. Caro A.A., and Cederbaum A.I. Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine. Biochem. Pharmacol. 69 (2005) 1081-1093
32. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98 (1996) 5-7
33. Refsum H., Ueland P.M., Nygard O., and Vollset S.E. Homocystéine et maladies cardiovasculaires. Annu. Rev. Med. 49 (1998) 31-62
34. Friso S., and Choi S.W. The potential cocarcinogenic effect of vitamin B12 deficiency. Clin. Chem. Lab. Med. 43 (2005) 1158-1163
35. Kato I., Dnistrian A.M., Schwartz M., Toniolo P., Koenig K., Shore R.E., et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br. J. Cancer 79 (1999) 1917-1922
36. Laird P.W., and Jaenisch R. DNA methylation and cancer. Hum. Mol. Genet. 3 (1994) 1487-1495
37. Akoglu B., Milovic V., Caspary W.F., and Faust D. Hyperproliferation of homocysteine-treated colon cancer cells is reversed by folate and 5-methyltetrahydrofolate. Eur. J. Nutr. 43 (2004) 93-99
38. Quere I., Chasse J.F., Dupuy E., Bellet E., Molho-Sabatier P., Tobelem G., et al. Homocystéine, 5,10-methylenetetrahydrofolate reductase et thrombose veineuse profonde. Etude de 120 patients dans un service de médicine interne. Rev. Med. Interne 19 (1998) 29-33
39. Corona G., Toffoli G., Fabris M., Viel A., and Zarrelli A. C. Donada and all., Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells. Eur. J. Cancer 33 (1997) 1284-1290
40. Weinstein S.J., Ziegler R.G., Selhub J., Fears T.R., Strickler H.D., Brinton L.A., et al. Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12 (2001) 317-324
41. Sciacca F.L., Ciusani E., Silvani A., Corsini E., Frigerio S., Pogliani S., et al. Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin. Cancer Res. 10 (2004) 1312-1317
42. Hultdin J., Van Guelpen B., Bergh A., Hallmans G., and Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int. J. Cancer 113 (2005) 819-824
43. Glynn S.A., Albanes D., Pietinen P., Brown C.C., Rautalahti M., Tangrea J.A., et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev. 5 (1996) 487-494
44. Wu L.L., and Wu J.T. Hyperhomocystéinémia is a risk factor for cancer and a new potential tumor marker. Clin. Chim. Acta 322 (2002) 21-28
45. Sun C.F., Haven T.R., Wu T.L., Tsao K.C., and Wu J.T. Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Clin. Chim. Acta 321 (2002) 55-62
46. Buemi M., Marino D., Di Pasquale G., Floccari F., Ruello A., Aloisi C., et al. Effects of homocysteine on proliferation, necrosis, and apoptosis of vascular smooth muscle cells in culture and influence of folic acid. Thromb Res. 104 (2001) 207-213
47. Guo H., Lee J.D., Uzui H., Yue H., Wang J., Toyoda K., et al. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circ. J. 70 (2006) 141-146